Volume 25, Issue 5

Search all Pituitary articles

Volume 25, Issue 5

October 2022

Special Issue: Cushing's disease in the new decade

Issue Editor:

MARIA FLESERIU

22 articles in this issue

Special issue: Cushing's disease update
Maria Fleseriu
Editorial 24 August 2022 Pages: 687 - 688
Genetics of Cushing’s disease: from the lab to clinical practice
Marily Theodoropoulou
Martin Reincke
ReviewPaper Open access 19 July 2022 Pages: 689 - 692
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome
Stephan Petersenn
ReviewPaper 11 July 2022 Pages: 693 - 697
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)
Hershel Raff
ReviewPaper 25 March 2022 Pages: 698 - 700
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)
Carla Scaroni
Alessandro Mondin
Filippo Ceccato
OriginalPaper Open access 26 May 2022 Pages: 701 - 704
Biochemical testing to differentiate Cushing’s disease from ectopic ACTH syndrome
Amandine Ferriere
Antoine Tabarin
Review 27 June 2022 Pages: 705 - 708
Modern imaging in Cushing’s disease
W. A. Bashari
D. Gillett
M. Gurnell
Review Open access 06 June 2022 Pages: 709 - 712
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation
Pamela S. Jones
Brooke Swearingen
ReviewPaper 20 July 2022 Pages: 713 - 717
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation
Maria Balomenaki
Dimitra A. Vassiliadi
Stylianos Tsagarakis
ReviewPaper 17 May 2022 Pages: 718 - 721
Part of 1 collection:

Special Issue: Cushing's disease in the new decade: highlights from the Pituitary Society Cushing's Consensus Meeting
Pituitary acting drugs: cabergoline and pasireotide
Mônica R. Gadelha
Luiz Eduardo Wildemberg
Ilan Shimon
ReviewPaper 07 June 2022 Pages: 722 - 725
Cushing’s disease: adrenal steroidogenesis inhibitors
Rosario Pivonello
Chiara Simeoli
Annamaria Colao
ReviewPaper Open access 29 August 2022 Pages: 726 - 732
Glucocorticoid receptor blockers
Mark E. Molitch
ReviewPaper 04 May 2022 Pages: 733 - 736
Part of 1 collection:

Special Issue: Cushing's disease in the new decade: highlights from the Pituitary Society Cushing's Consensus Meeting
Cushing’s disease: role of preoperative and primary medical therapy
Frederic Castinetti
Review 02 July 2022 Pages: 737 - 739
Role of Radiation in the treatment of Cushing Disease
Laurence Katznelson
OriginalPaper 10 June 2022 Pages: 740 - 742
Cushing’s disease: role of bilateral adrenalectomy
Jérôme Bertherat
ReviewPaper 26 July 2022 Pages: 743 - 745
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
Richard A. Feelders
Lynnette K. Nieman
ReviewPaper Open access 26 July 2022 Pages: 746 - 749
Cardiovascular health and mortality in Cushing’s disease
Amy Coulden
Ross Hamblin
Niki Karavitaki
ReviewPaper Open access 22 July 2022 Pages: 750 - 753
Novel approaches to bone comorbidity in Cushing’s disease: an update
Stefano Frara
Luigi di Filippo
Andrea Giustina
ReviewPaper 18 July 2022 Pages: 754 - 759
Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease
Cesar Luiz Boguszewski
ReviewPaper 13 May 2022 Pages: 760 - 763
Part of 1 collection:

Special Issue: Cushing's disease in the new decade: highlights from the Pituitary Society Cushing's Consensus Meeting
Cushing’s disease in children: unique features and update on genetics
Constantine A. Stratakis
ReviewPaper 24 June 2022 Pages: 764 - 767
Quality of life impairment after a diagnosis of Cushing’s syndrome
Susan M Webb
Elena Valassi
Review Open access 29 June 2022 Pages: 768 - 771
Pituitary tumor centers of excellence for Cushing’s disease
Marcos Couselo
Stefano Frara
Felipe F. Casanueva
OriginalPaper Open access 10 September 2022 Pages: 772 - 775

Volume 25, Issue 5

Search

Navigation